Project Proposal 2022 Call is closed.

Thank you for submitting your applications, the outcome will be communicated in autumn 2022.

For any questions please contact


  • An investigator cannot apply in more than one project as a Project Leader in a single round proposal;
  • An investigator cannot apply as a Project Leader if he/she already has an approved project that is being funded by the PPRC and has not been completed;
  • Executive officers of the EADV are not eligible to apply for a grant by the PPRC as Project Leaders;
  • Board members and Committee chairs/members may apply as Project Leaders or co-investigators for PPRC funding but cannot be personally compensated through the grant;
  • Funding will be firstly allocated at the end of the submission year;
  • The funding period essentially starts at the beginning of the year that follows the submission. Please consider this for the project timeplan and budget.

Criteria for evaluation:

A project which is in conflict with EADV or is in conflict with EADV initiatives pursued by other committees of EADV, will not be evaluated by the PPRC.

  • The project benefits the EADV: the project will contribute to the mission and reputation of the EADV;
  • The project benefits patients with skin diseases and contributes to the understanding of skin diseases, physician capabilities or patient care;
  • The project involves several expert groups from European countries with a synergistic or complementary role in pursuing the objectives of the project;
  • The project is co-ordinated by investigators with sufficient background experience and/or training in the specific research field;
  • The project is original and carries true scientific or clinical interest;
  • The project is feasible: the project objectives are realistic and can be achieved within a reasonable time frame (1-2 years);
  • The project management plan is adequate: timing and resources are clearly specified and in line with the project requirements. Deliverables are clear and measurable;
  • The project budget is adequate: a detailed realistic budget with justification of all elements is provided.

Evaluation and submission results

Each project will be reviewed by each member of the Project Proposal and Review Committee. When necessary, external reviewers (1 or 2) may be asked for their expertise at the decision of the Committee. External reviewers will be former or current members of the EADV Board.


Project proposals are reviewed by the PPRC committee, and submitted to the attention of the Board of Representatives.

Final decision will be taken by the Board of Representatives at the EADV Board meeting held during the EADV annual congress.

Submitters will be informed soon after the Board meeting of the result related to their project submission.


The budget limit on project funding is 100.000 Euros.
The budget includes:

  • Salary for project leader and other essential personnel;
  • Equipment, supplies and software;
  • Facilities and administrative costs;
  • Travel expenses;
  • Publications and miscellaneous costs.

How do I submit my project?

You can send us your project proposal and description on the EADV website through the link available below.

Read carefully the Project Proposal guidelines (Printable PDF).

Projects must be submitted online only ( click here for a preview of the application form).

The Committee does not provide a detailed review for non-approved projects.

No hard copies will be accepted.

Any questions? Contact us

2021 Successful Applicants

Lead Investigator
Sarah Guégan
Cochin Hospital, AP-HP and University of Paris
Identification of novel therapeutic targets in the large/giant congenital melanocytic nevus through high-resolution transcriptomics
Khalaf Kridin
Bar-Ilan University
Establishing the clinical and immunological characteristics and investigating the effects of DPP4i on the main events underlying the pathogenesis of BP
Christos Tziotzios
United Kingdom
St John's Institute of Dermatology, King's College London
Translational Research Study for Effective Alopecia Treatments in Frontal Fibrosing Alopecia
Phyllis Spuls
Amsterdam University Medical Center AMC
Skin Inflammation and Psoriasis International Network Methotrexate Dosing Consensus Survey in patients with Atopic Dermatitis (AD)
Secil Vural
Koç University School of Medicine
Unveiling the pathomechanism of Behçet's Disease
Jose Manuel Carrascosa
Hospital Universitari Germans Trias i Pujol
Methylome-based clustering of atopic dermatitis: correlation with disease activity and response to conventional and new therapies
Susanne Kimeswenger
Johannes Kepler University Linz
Interpretability of Neural Networks for Dermatohistopathology